ArticleScience translational medicine2025

CD154 blockade effectively controls antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients.

Imran J Anwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.